Skip to main content
    O

    Organon & Co (OGN)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE

    $13.90
    +0.00 (+0.00%)

    Market Cap: $3.65B

    Last updated: Nov 17, 2026 at 4:20 PM ET

    Organon & Co (OGN) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Organon (OGN) has a market cap of $3.65B and an enterprise value of $10.75B. Its net debt of $7.10B equals 194.47% of its market cap.

    Total Valuation

    Enterprise value is 194.47% above the market cap, as debt exceeds cash.

    Market Cap$3.65B
    Enterprise Value$10.75B
    Latest price (Nov 17, 2026)$13.90

    Key Dates

    The next earnings report is expected on Feb 10, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Nov 9, 2026.

    Next Earnings DateFeb 10, 2027 (expected)
    Last Earnings DateOct 30, 2026
    Last Ex-Dividend DateNov 9, 2026
    Next Payment DateDec 10, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count held steady in the quarter ended Sep 30, 2026 and grew 0.99% a year over 2 years.

    Shares Outstanding262.62M
    Shares Change (YoY)+1.02%
    Shares Change (QoQ)0.00%
    Share Count Growth (2Y CAGR)+0.99%

    Valuation Ratios

    Sales and book value multiples are 0.6x and 3.1x. Its year-end P/E ranged from 2.0x to 5.6x from 2021 to 2025.

    P/E Ratio4.6x
    Forward P/E4.0x
    P/S Ratio0.6x
    Forward P/S0.6x
    P/B Ratio3.1x
    P/FCF Ratio5.4x
    P/OCF Ratio4.3x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 8.4x EBITDA and 15.9x free cash flow.

    EV / Earnings50.5x
    EV / Sales1.8x
    EV / EBITDA8.4x
    EV / EBIT11.5x
    EV / FCF15.9x

    Price Statistics

    The stock is up 85.86% over 52 weeks and trades 1.09% above its 50-day average.

    Beta (1Y)0.57
    52-Week Change+85.86%
    1-Month Change+1.24%
    3-Month Change+1.38%
    6-Month Change+3.73%
    5-Year Change-62.34%
    Total Return (1Y)+87.20%
    Total Return (3Y CAGR)+10.37%
    Total Return (5Y CAGR)-11.77%
    Return vs SPY (1Y)+69.96%
    Max Drawdown (1Y)-41.54%
    Max Drawdown (3Y)-74.12%
    Sharpe Ratio (1Y)1.11
    Correlation with SPY (1Y)0.15
    50-Day Average$13.75
    200-Day Average$11.78
    52-Week Range$5.67 to $13.91
    RSI (14 Days)69.2
    Average Volume (20 Days)2.75M

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.02x current liabilities, and total debt is 7.17x shareholder equity.

    Current Ratio2.02x
    Quick Ratio1.51x
    Debt / Equity7.17x
    Debt / EBITDA6.68x
    Debt / FCF12.67x
    Interest Coverage2.16x

    Returns and Efficiency

    Return on invested capital is 6.25% over the last 12 months, against a 5-year average of 14.17%.

    Return on Equity (ROE)17.85%
    Return on Assets (ROA)1.59%
    Return on Invested Capital (ROIC)6.25%
    Return on Capital Employed (ROCE)8.72%
    ROA (5Y Average)7.51%
    ROIC (5Y Average)14.17%
    Asset Turnover0.45x
    Inventory Turnover2.11x
    Receivables Turnover4.10x
    Cash Conversion Cycle132 days

    Taxes

    Income tax took 57.65% of pretax income over the last 12 months.

    Income Tax (TTM)$290.00M
    Effective Tax Rate57.65%

    Scores

    OGN has an Altman Z-Score of 1.27, in the distress zone below 1.81, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.

    Altman Z-Score1.27
    Altman Z ZoneDistress
    Piotroski F-Score5 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $6.10B over the last 12 months is down 3.21% from the 12 months before.

    Revenue$6.10B
    Revenue Growth (YoY)-3.21%
    Gross Profit$3.24B
    Operating Income$831.00M
    Pretax Income$503.00M
    Net Income$213.00M
    EBITDA$1.28B
    EBIT$937.00M
    Reported EPS (TTM)$3.02

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 8.88% of the $13.40B in total assets.

    Cash and Equivalents$1.46B
    Total Debt$8.55B
    Net Debt$7.10B
    Net Debt Per Share$27.03
    Working Capital$2.72B
    Shareholder Equity$1.19B
    Book Value Per Share$4.54
    Tangible Book Value-$4.03B
    Total Assets$13.40B
    Total Liabilities$12.21B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $168.00M of capital spending, operating cash flow left $675.00M of free cash flow.

    Operating Cash Flow$843.00M
    Capital Expenditures$168.00M
    Free Cash Flow$675.00M
    FCF Per Share$2.57
    Depreciation and Amortization$344.00M
    Dividends Paid$20.00M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 13.63%, against a 5-year average of 21.72%.

    Gross Margin53.12%
    Operating Margin13.63%
    Pretax Margin8.25%
    Net Margin3.49%
    EBITDA Margin21.00%
    EBIT Margin15.36%
    FCF Margin11.07%
    Gross Margin (5Y Average)59.19%
    Operating Margin (5Y Average)21.72%
    Net Margin (5Y Average)13.82%

    Growth

    Revenue grew 0.23% a year over 3 years, and EPS fell 10.06% a year.

    Revenue Growth (3Y CAGR)+0.23%
    Revenue Growth (5Y CAGR)-0.99%
    EPS Growth (3Y CAGR)-10.06%
    FCF Growth (3Y CAGR)-6.68%
    FCF Growth (5Y CAGR)-23.32%
    Operating Income Growth (3Y CAGR)-19.34%

    Revenue and profit by year

    Dividends and Yields

    OGN pays out 3.12% of earnings as dividends.

    Dividend Per Share (Annual)$0.08
    Dividend Yield0.58%
    Payment ScheduleQuarterly
    Dividend Growth (3Y CAGR)-62.30%
    Payout Ratio3.12%
    FCF Payout Ratio2.96%
    Earnings Yield21.74%
    FCF Yield18.49%
    Shareholder Yield0.55%

    Full dividend history

    Peer Position

    Against 8 similar companies, OGN has the lowest P/E and the 6th highest ROIC.

    P/E Ratio4.6x vs 27.3x median
    P/S Ratio0.6x vs 4.5x median
    ROIC6.25% vs 7.28% median
    Revenue Growth (Trailing 4 Quarters, YoY)-3.21% vs +5.62% median
    Dividend Yield0.58% vs 0.00% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 0.56% and EPS growth at -0.17% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+0.56%
    EPS Growth Forecast (2Y CAGR)-0.17%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About OGN

    What is OGN's market cap?

    Organon has a market cap of $3.65B. Its enterprise value, which adds debt and subtracts cash, is $10.75B.

    What is OGN's P/E ratio?

    Organon has a trailing P/E ratio of 4.6x and a forward P/E of 4.0x.

    How many shares of OGN are outstanding?

    Organon has 262.62M shares outstanding. The count is up 1.02% from a year earlier.

    Does OGN pay a dividend?

    Yes. Organon pays $0.08 a share a year, a dividend yield of 0.58%.

    How much debt does OGN have?

    Organon has $8.55B of total debt and $1.46B of cash and equivalents, a net debt position of $7.10B.